Gilead Launches New Grants Program to Support HIV Cure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. PYPL
3. KLAC
4. SPY
5. STX
6. CSGP
7. BE
8. SWKS
9. F
10. MSFT

Go back to Gilead Launches New Grants Program to Support HIV Cure
Gilead Sciences (NASDAQ: GILD) Delayed: 132.73 -1.59 (1.18%)
Previous Close $134.32    52 Week High $108.63 
Open $134.41    52 Week Low $71.39 
Day High $134.64    P/E 73.33 
Day Low $132.57    EPS $1.81 
Volume 7,493,697